Tris-CAR-T cell injection: Clinical Trials

1 trial of Tris-CAR-T cell injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1
Phase 31Not yet recruiting 1

Follow Tris-CAR-T cell injection: new trials by email Literature Review of Tris-CAR-T cell injection trials Research Report on Tris-CAR-T cell injection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tris-CAR-T Cell Therapy Targeting CD44 and CD133 in Newly Diagnosed Glioblastoma
Tris-CAR-T cell injection, Ommaya reservoir implantation, Temozolomide (TMZ) - Newly Diagnosed Glioblastoma, IDH-wildtype
Phase 2 / Phase 3Not yet recruitingBeijing Tiantan Hospital602026-10-152026-10-14

Conditions studied

Glioblastoma (1)

Sponsors

Beijing Tiantan Hospital (1)

Countries

China (1)

Top investigators

Tao Jiang, MD, PhD (1)  ·  Wei Zhang, MD, PhD (1)

Results publications

PMID 39952598